Beneficial effect of prostaglandin E1 on blood flow to the gastric tube after esophagectomy

Annals of Thoracic Surgery

Volumn 67, Issue 4, 1999, Pages 908-910

  Matsuzaki, Yasunori ^a   Edagawa, Masao ^a   Maeda, Masayuki ^a   Shimizu, Tetsuya ^a   Sekiya, Ryo ^a   Nakamura, Kunihide ^a   Onitsuka, Toshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; BLOOD FLOWMETRY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGOGASTROSTOMY; ESOPHAGUS CANCER; ESOPHAGUS RECONSTRUCTION; ESOPHAGUS RESECTION; FEMALE; HUMAN; MALE; MICROCIRCULATION; PRIORITY JOURNAL; STOMACH TUBE; SURGICAL TECHNIQUE; VASODILATATION;

ADULT; AGED; ALPROSTADIL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOPLASTY; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STOMACH; VASODILATOR AGENTS;

EID: 0032942229     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00065-X     Document Type: Article

References (14)

1. Patil P.K., Patel S.G., Mistry R.C., Deshpande R.K., Desai P.B. Cancer of the esophagus esophagogastric anastomotic leak - a retrospective study of predisposing factors . J Surg Oncol. 49:1992;163-167.
2. Moncada S., Flower R.J., Vane J.R. Prostaglandins, prostacyclin, thromboxane A2, and leukotrienes. Gilman A.G., Goodman L.S., Rall T.W., Murad F. The pharmacological basis of therapeutics. 7 ed. 1985;660-673 MacMillan, New York.
3. 1 treatment of pulmonary hypertension. Am Rev Respir Dis. 136:1987;773-776.
4. Mulvin D., Jones K., Howard R., Grosso M., Repine J. The effect of prostacyclin as a constituent of a preservation solution in protecting lungs from ischemic injury because of its vasodilatory properties. Transplantation. 49:1990;828-830.
5. Vane J.R. Adventures and excursions in bioassay - the stepping stones to prostacyclin. Postgrad Med J. 59:1983;743-758.
6. Hooper T.L., Thomson D.S., Jones M.T. Amelioration of lung ischemic injury with prostacyclin. Transplantation. 49:1990;1031-1035.
7. Rovert A. Cytoprotection by prostaglandins. Gastroenterology. 77:1979;761-767.
8. Fantone J.C., Kunkel S.L., Ward P.A., Zurier R.B. Suppression by prostaglandin E1 of vascular permeability induced vasoactive inflammatory mediators. J Immunol. 125:1980;2591-2596.
9. Fantone J.C., Marasco W.A., Elgas L.T., Ward P.A. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. Am J Pathol. 115:1984;9-16.
10. Matsuzaki Y., Waddell T.K., Puskas J.D., et al. Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1. Am Rev Respir Dis. 148:1993;882-889.
11. Dubois P., Choiniere L., Cooper J.D. Bronchial omentopexy in canine lung allotransplantation. Ann Thorac Surg. 38:1984;211-214.
12. Menger M.D., Jaeger S., Puskas J.D., Walter P., Feifel G., Messmer K. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes. 38:1989;199-201.
13. Adams W., Ctercteko G., Bilous M. Effect of an omental wrap on the healing and vascularity of compromised intestinal anastomosis. Dis Colon Rectum. 35:1992;731-738.
14. Hickey M.J., Wilson Y., Hurley J.V., Morrison W.A. Model of vascularization of control and basic fibroblast growth factor-stimulated prefabricated skin flap. Plat Reconstr Surg. 101:1998;1296-1304.